Bruker Corporation (BRKR)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Bruker Corporation currently loses $6.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 2
in 53 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Bruker’s adjusted EPS of $0.49 topped the $0.38 estimate, +27%, in preliminary second fiscal quarter of 2026 results reported Aug. 4. Revenue rose 5.2% to about $838.5 million from $797.4 million a year ago, but it trailed the $853.6 million estimate by 1.8%. Gross profit was about $416.0 million and gross margin was near 49.6%, while operating cash flow was negative at about $77.4 million and the company paid about $18.5 million in dividends. Consensus for the next period calls for EPS of $0.42 on revenue of $867.4 million.
About Bruker Corporation
Bruker Corporation develops scientific and medical-device instrumentation for life sciences, diagnostics, and advanced research markets. Listed on NASDAQ as BRKR, the company generated $3.4 billion in FY2025 revenue from platforms that span mass spectrometry, imaging, molecular testing, nanotechnology tools, and superconducting materials.
Today's Snapshot
The day ended with BRKR 6.8% lower at 54.43, while its sector was flat. Shares changed hands at about half as much again as its usual level. UBS, an investment bank, began covering Bruker and rated its shares Neutral with a $65 target.
Trading Volume
Above 10d avg 1.9M
2.8M
vs S&P 500 Today
Strong Underperformance
-6.33%
Updated: September 9, 2026 at 20:13 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$48.95 - $57.73Sell
- RSI (14)42.15Neutral
- Stochastic %K (14, 3, 3)34.00Neutral
- MACD Level (12, 26)-0.20Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.